葡萄糖皮质激素介导的骨肌肉缩:分子机制和潜在的治疗点
Uttapol Permpoon1, Jiyeong Moon1, Chul Young Kim1
1Department of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea.
International journal of molecular sciences
|August 14, 2025
概括
葡萄糖皮质体 (GCs) 通过激活葡萄糖皮质体受体 (GR) 引起肌肉缩. 了解GR途径为肌肉消耗疾病提供了新的治疗策略.
科学领域:
- 肌肉生理学和内分泌学.
- 肌肉缩的分子机制
- 对代谢障碍的药物发现.
背景情况:
- 骨肌肉缩会降低生活质量,特别是在老年人群和患有慢性疾病的人群中.
- 葡萄糖皮质体 (GCs) 对于恒温至关重要,但长时间暴露会通过葡萄糖皮质体受体 (GR) 诱导肌肉缩.
- 目前针对GC诱导肌肉缩的现有治疗方法的临床疗效有限.
研究的目的:
- 探索参与GC介导的骨肌缩的新兴途径.
- 为了识别超越当前对手的新疗法目标.
- 为了深入了解GR在肌肉代谢中的作用.
主要方法:
- 对骨肌肉中GC信号传递的当前文献的综述.
- 对最近发现的分子通路的分析,包括SIRT6,LSD1,kynurenine通路和IDO-1.
- 检查GR的交换激活和转压机制.
主要成果:
- 通过激活GR,GCs促进肌肉缩,从而抑制蛋白质合成并增强分解.
- 新兴的目标包括抑制AKT/mTORC1信号的GC诱导的Sirtuin 6异型 (SIRT6).
- 氨酸特异性去甲基酶1 (LSD1) 和 kynurenine 途径 (IDO-1) 涉及到 atrogen 转录和肌肉代谢.
结论:
- 肌肉缩的新型治疗策略需要对GR信号复杂性的全面了解.
- 针对SIRT6,LSD1和kynurenine通路等途径可能为治疗GC诱导的肌肉衰竭提供新的途径.
- 为了开发有效的治疗方法,对GR交换激活和转压抑的进一步研究至关重要.
相关概念视频
Cross-bridge Cycle
118.3K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.3K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Skeletal Muscle Relaxants: Adverse Effects
471
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
471
Skeletal Muscle Relaxants: Therapeutic Uses
616
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
616


